OverviewChartNewsTraderScreen

BVT Aktienanleihe AMD 28.06.2024/  DE000VU68U46  /

Frankfurt Zert./VONT
2024-04-26  7:42:48 PM Chg.-0.010 Bid7:42:48 PM Ask7:42:48 PM Underlying Strike price Expiration date Option type
101.360EUR -0.01% -
Bid Size: -		 -
Ask Size: -		 ADVANCED MIC.DEV. D... 80.00 - 2024-06-28 Call
TeleTrader 04-26 Intel shares plunge 11% to 10-month low on gloomy outlook
GlobeNewswire 04-26 Belite Bio Announces $25 Million Registered Direct Offering
GlobeNewswire 04-25 Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientif...
GlobeNewswire 04-23 YieldMax™ Launches Bitcoin Option Income Strategy ETF YBIT
GlobeNewswire 04-18 Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
GlobeNewswire 04-16 AMD to Report Fiscal First Quarter 2024 Financial Results
TeleTrader 04-16 AMD launches AI chips for business laptops and desktops
GlobeNewswire 04-16 Micron First to Production of 200+ Layer QLC NAND in Client and Data Center
GlobeNewswire 04-16 AMD Expands Commercial AI PC Portfolio to Deliver Leadership Performance Across Professional Mobile ...
GlobeNewswire 04-16 Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Dir...
GlobeNewswire 04-16 Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
GlobeNewswire 04-15 Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million
GlobeNewswire 04-15 Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessi...
GlobeNewswire 04-12 BOXX Showcases Full Line of Media & Entertainment Workstations at 2024 NAB Show
TeleTrader 04-12 China tells telecom carriers to eliminate foreign chips by 2027
GlobeNewswire 04-09 Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Senior Vice Pre...
TeleTrader 04-09 BlackBerry, AMD partner to enhance robotics precision
GlobeNewswire 04-09 AMD Extends Leadership Adaptive SoC Portfolio with New Versal Series Gen 2 Devices Delivering End-to...
GlobeNewswire 04-09 Opthea Appoints John Han, PharmD, as VP Medical Affairs
GlobeNewswire 04-06 Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™ Glaucoma Data at the American Society of Ca...
GlobeNewswire 04-05 Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference 
TeleTrader 04-04 US closes lower ahead of jobs data, Dow tumbles 500 pts
GlobeNewswire 04-03 Opthea Appoints Sujal Shah to the Board of Directors
GlobeNewswire 04-03 YieldMax™ ETFs Announces Monthly Distributions on MSTY (120.57%), CONY (119.30%), NVDY (106.86%), AM...
GlobeNewswire 04-02 EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists